Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients

The aim of this retrospective cohort study was to compare safety, efficacy and rates and reasons of discontinuation of the 3 currently approved integrase strand transfer inhibitors (INSTIs) elvitegravir (EVG), dolutegravir (DTG), and raltegravir (RAL) in HIV-infected treatment-naïve and -experienced...

Descripción completa

Detalles Bibliográficos
Autores principales: Brehm, Thomas Theo, Franz, Marleen, Hüfner, Anja, Hertling, Sandra, Schmiedel, Stefan, Degen, Olaf, Kreuels, Benno, Schulze zur Wiesch, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708907/
https://www.ncbi.nlm.nih.gov/pubmed/31393378
http://dx.doi.org/10.1097/MD.0000000000016721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708907/
https://www.ncbi.nlm.nih.gov/pubmed/31393378
http://dx.doi.org/10.1097/MD.0000000000016721

Ejemplares similares